Impacts of genomic networks governed by human-specific regulatory sequences and genetic loci harboring fixed human-specific neuro-regulatory single nucleotide mutations on phenotypic traits of modern humans
September 20, 2020
recent advances in the identification and characterization of the human DNA sequence-specific regulation set the stage for a global assessment of their impact on the physiology and pathology of modern humans. Gene set enrichment analysis (GSEA) on 8405 35 074 human genes associated with neuro-regulatory-specific single nucleotide changes (hsSNCs) revealed numerous significant association with morphological structure, physiological processes and pathological conditions of modern man.
Significantly enhanced properties including more than 1000 different anatomical regions of the adult human brain, different types of cells and tissues, more than 200 human disorders are common, and more than 1000 records of rare diseases. HsSNCs thousands of genes connected with neuro-regulation have been identified, which represent an important genetic elements of autosomal inheritance and child survival phenotype. A total of 1,494 hsSNC-linked genes associated with either autosomal dominant or recessive, and 2273 genes related hsSNC has been linked to premature death, lethal embryos, as well as pre, peri, neo, and post-natal lethal phenotype of both complete and incomplete penetration.
Differential GSEA implemented on hsSNC-linked loci and genes associated to identify a set of 7990 hsSNC-target gene linked to a different class the evolution of human-specific regulatory sequence (hypersensitivity reaction). In particular, the expression of the majority of these genes (genes 5389; 67%) set by the sequence of stem cell-related retroviral (scar) and scar-regulated genes were arrested dominant fraction (91%) of the association of phenotype that was significantly associated with hsSNCs. MGI interrogation of databases revealed mouse models are available tailored to the exact experimental definition of the functional effects hsSNCs and scars on the causal genes that affect the phenotype of thousands of mammals and human beings are involved in hundreds of common and rare disorders.
These observations indicate that the dominant nature of certain men thrive under regulatory control combinations of different classes of a HSR and neuro-regulatory hsSNCs locus storing fixed in humans, is different from other primates, and is located in the region of chromatin vary accessed during brain development ,
Impacts of genomic networks governed by human-specific regulatory sequences and genetic loci harboring fixed human-specific neuro-regulatory single nucleotide mutations on phenotypic traits of modern humans
Genetic Diversity of Human Immunodeficiency Virus Type 1 in asymptomatic blood donors in Islamabad, Pakistan
The goal serological testing for human immunodeficiency virus (HIV) is mandatory under the security laws in the blood of Pakistan; Therefore, the existing data on the prevalence of HIV in the blood donor. However, little is known about the molecular epidemiology of HIV in the blood donor population.
Therefore, this study was designed to study the genetic diversity of HIV-1 infection in treatment-naïve population of apparently healthy blood donors in Islamabad, Pakistan. Materials and Methods A total of 85 736 blood donors tested for HIV by chemiluminescence immunoassay. All samples were positive donor were analyzed for the presence of various HIV genotypes (types and subtypes). viral ribonucleic acid extracted from blood samples from HIV-positive donors and reverse transcribed into a complementary deoxyribonucleic acid (cDNA).
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Unconjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Unconjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Unconjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Unconjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is HRP conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is FITC conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Biotin conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is HRP conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is FITC conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Biotin conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is HRP conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is FITC conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Biotin conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is HRP conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is FITC conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Biotin conjugated. Tested in the following application: ELISA
The cDNA of all positive donor were then analyzed for the presence of various HIV genotypes (types and subtypes) using the primer specific subtype in a nested polymerase chain reaction. Products powered run on ethidium bromide-stained 2% agarose gel and visualized using ultraviolet Transilluminator. A particular subtype is assigned to a specific subtype samples if the reaction made the band a very intense 20% compared to the band made by subtype-independent reaction.
)
)
)
)
)
)
 Antibody)
)
)
)
 Antibody (Biotin Conjugate))
 AssayLite Antibody (FITC Conjugate))
 AssayLite Antibody (RPE Conjugate))
 AssayLite Antibody (APC Conjugate))
 AssayLite Antibody (PerCP Conjugate))
)
)
 Protein)
)
)
)
 Protein (aa 1-3412))
 Antibody)
 ELISA Kit)
 Antibody)
, CF)
)
 Antibody (Biotin))
 Antibody (FITC))
)
)
